0.72
+0.011(+1.56%)
Currency In USD
Address
2200 N. Commerce Parkway
Weston, FL 33326
United States of America
Phone
754 231 1688
Website
Sector
Healthcare
Industry
Biotechnology
Employees
7
First IPO Date
February 11, 2022
| Name | Title | Pay | Year Born |
| Mr. Stephen C. Glover | Co-Founder, Chairman, Chief Executive Officer & President | 550,000 | 1960 |
| Dr. Pablo A. Guzman FACC, M.D. | Chief Medical Officer, Senior Vice President of Medical Affairs & Chairman of Renal Scientific Advisory Board | 350,000 | 1950 |
| Mr. Peter Wolfe | Chief Financial Officer & Secretary | 395,000 | 1968 |
ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It engages in the development of VAR 200, a cholesterol efflux mediator to treat focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney disease; and IC 100, a novel inflammasome ASC inhibitor for treatment of multitude of inflammatory diseases. ZyVersa Therapeutics, Inc. is headquartered in Weston, Florida.